ONCOINVENT
Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
ONCOINVENT
Social Links:
Industry:
Biotechnology Chemical Life Science
Founded:
2010-08-10
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.oncoinvent.com
Total Employee:
11+
Status:
Active
Contact:
+4722183305
Total Funding:
60.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Oxitec
Oxitec develops an environment-friendly technology for the control of significant insect pests to prevent diseases and agricultural damage.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Current Advisors List
Current Employees Featured
Founder
Investors List
Watrium AS
Watrium AS investment in Venture Round - Oncoinvent
Geveran Trading
Geveran Trading investment in Venture Round - Oncoinvent
MP Pensjon
MP Pensjon investment in Venture Round - Oncoinvent
MUSST Investments
MUSST Investments investment in Venture Round - Oncoinvent
Hadean Ventures
Hadean Ventures investment in Venture Round - Oncoinvent
Sundt AS
Sundt AS investment in Venture Round - Oncoinvent
Canica
Canica investment in Venture Round - Oncoinvent
RADFORSK Investeringsstiftelse
RADFORSK Investeringsstiftelse investment in Venture Round - Oncoinvent
Alpine Capital AS
Alpine Capital AS investment in Venture Round - Oncoinvent
CGS Holding
CGS Holding investment in Venture Round - Oncoinvent
Official Site Inspections
http://www.oncoinvent.com Semrush global rank: 5.47 M Semrush visits lastest month: 1.56 K
- Host name: bristol.domeneshop.no
- IP address: 194.63.248.52
- Location: Norway
- Latitude: 59.9452
- Longitude: 10.7559
- Timezone: Europe/Oslo
More informations about "Oncoinvent"
About Oncoinvent
About Oncoinvent Oncoinvent is a privately held radiopharmaceutical company based in Oslo, Norway. The company is committed to developing new innovative products in order to provide better treatment options for cancer patients. …See details»
Oncoinvent - Crunchbase Company Profile & Funding
Organization. Oncoinvent . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Oncoinvent AS designs and develops cancer treatments by applying known physical and …See details»
Oncoinvent ASA - LinkedIn
Oncoinvent ASA | 2,753 followers on LinkedIn. Innovations for better cancer care | Oncoinvent is a clinical stage company committed to developing new innovative radiopharmaceutical …See details»
Annual Report 2021 Oncoinentv
Formance, Oncoinvent aims to raise NOK 150-200 million to move into efficacy studies with Radspherin®. Read more online + Oncoinvent to present four posters at the 34th Annual …See details»
Oncoinvent AS | European Clinical Trials Information Network
Oncoinvent AS is a Norwegian-based biotechnology company that specializes in the development of innovative radiopharmaceuticals for the treatment of cancer. Founded in 2010, the company …See details»
Oncoinvent Company Profile - Office Locations, Competitors, …
Oncoinvent has 5 employees at their 1 location and $29.02 m in total funding,. See insights on Oncoinvent including office locations, competitors, revenue, financials, executives, …See details»
Oncoinvent Announces Changes to its Board of Directors and …
Apr 2, 2024 Oncoinvent’s lead candidate, Radspherin ®, is designed for treatment of metastatic cancers in body cavities, and its versatility allows it to be deployed for the treatment of a …See details»
Oncoinvent ASA announces oversubscribed private placement
2 days ago OSLO, Norway, Dec. 5, 2024 /PRNewswire/ -- Oncoinvent ASA ('Oncoinvent' or the 'Company') is pleased to announce that it has today successfully completed the bookbuilding …See details»
Oncoinvent AS, Financial Info, Board and Management, …
Changes In Board and Management in last 6 months: Men: 0 Women: 0 GENDER BALANCESee details»
Oncoinvent - Contacts, Employees, Board Members, Advisors
Organization. Oncoinvent . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Oncoinvent has 2 board members and …See details»
Oncoinvent Announces Agreement with ARTBIO to Collaborate on …
3 days ago OSLO, Norway--(BUSINESS WIRE)--Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced that it has …See details»
Oncoinvent - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead ... obfuscated — May 19, 2020: Venture …See details»
Oncoinvent Announces Agreement with ARTBIO to Collaborate on ...
4 days ago Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced that it has entered into an agreement with ARTBIO, …See details»
Oncoinvent - Overview, News & Similar companies | ZoomInfo.com
Feb 21, 2024 Who is Oncoinvent. Oncoinvent AS is a clinical stage company developing innovative radiopharmaceutical technology that delivers precise, alpha-emitting particles acro …See details»
Oncoinvent - Products, Competitors, Financials, Employees, …
Oncoinvent Announces Promising Interim Results for Radspherin® as a Potential Treatment for Peritoneal Carcinomatoses. Nov 11, 2024. OSLO, Norway--(BUSINESS WIRE)--Oncoinvent …See details»
Oncoinvent Company Profile 2024: Valuation, Funding & Investors …
Oncoinvent General Information Description. Developer of pharmaceutical products intended to serve the healthcare sector. The company offers products for treatment by applying known …See details»
Reports and Presentations - Oncoinvent
[email protected]. Anders Månsson is a business executive with over 25 years of experience from management roles in the pharmaceutical industry, focusing on …See details»
Oncoinvent - VentureRadar
Oncoinvent is a privatley held company established 2010. The vision of the company is to bring new treatment options to cancer patients by developing novel antibody based therapetics. ...See details»
Oncoinvent
Oncoinvent Company presentation ... (whether within or outside such person's organization or firm) or published in whole or in part, by any medium or in any form for any purpose or under …See details»
Oncoinvent AS - The Hub
Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer …See details»